ID

20760

Beschrijving

Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01511692

Link

https://clinicaltrials.gov/show/NCT01511692

Trefwoorden

Versies (1)
  1. 15-03-17 15-03-17 -
Geüploaded op

15 maart 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Diabetes NCT01511692

Engels

Eligibility Diabetes NCT01511692

1 Formulieren  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01511692
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes mellitus
Beschrijving

Diabetes Mellitus, Non-Insulin-Dependent

Datatype

boolean

Alias
UMLS CUI [1]
C0011860
diet-treated subjects and/or subjects with type 2 diabetes in oad (oral anti-diabetic drug) mono-therapy
Beschrijving

Diet therapy Non-Insulin-Dependent Diabetes Mellitus | Antidiabetics Oral Non-Insulin-Dependent Diabetes Mellitus

Datatype

boolean

Alias
UMLS CUI [1,1]
C0012159
UMLS CUI [1,2]
C0011860
UMLS CUI [2,1]
C0935929
UMLS CUI [2,2]
C1527415
UMLS CUI [2,3]
C0011860
hba1c for diet-treated subjects: hba1c between 6.5-10.0% (both inclusive) and for oad treated subjects: hba1c between 6.5-9.5% (both inclusive)
Beschrijving

Glycosylated hemoglobin A Percentage Diet therapy | Glycosylated hemoglobin A Percentage Antidiabetics Oral

Datatype

boolean

Alias
UMLS CUI [1,1]
C0019018
UMLS CUI [1,2]
C0439165
UMLS CUI [1,3]
C0012159
UMLS CUI [2,1]
C0019018
UMLS CUI [2,2]
C0439165
UMLS CUI [2,3]
C0935929
UMLS CUI [2,4]
C1527415
body mass index (bmi) between 27-40 kg/m^2 (both inclusive)
Beschrijving

Body mass index

Datatype

boolean

Alias
UMLS CUI [1]
C1305855
subjects should have a stable body weight for at least 3 months prior to screening (as documented by a weight within 3 to 6 months, prior to screening that is within 15% of the screening weight)
Beschrijving

Stable body weight | Body Weight Screening procedure

Datatype

boolean

Alias
UMLS CUI [1]
C0517386
UMLS CUI [2,1]
C0005910
UMLS CUI [2,2]
C0220908
euthyroid subjects
Beschrijving

Euthyroid

Datatype

boolean

Alias
UMLS CUI [1]
C0117002
subjects should be unrestrained eaters
Beschrijving

Eating normal

Datatype

boolean

Alias
UMLS CUI [1]
C0566568
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
recurrent severe hypoglycaemia
Beschrijving

Recurrent severe hypoglycemia

Datatype

boolean

Alias
UMLS CUI [1]
C0342316
impaired liver function
Beschrijving

Liver Dysfunction

Datatype

boolean

Alias
UMLS CUI [1]
C0086565
impaired renal function
Beschrijving

Renal Insufficiency

Datatype

boolean

Alias
UMLS CUI [1]
C1565489
cardiac problems
Beschrijving

cardiac problem

Datatype

boolean

Alias
UMLS CUI [1]
C0262402
uncontrolled treated/untreated hypertension
Beschrijving

Uncontrolled hypertension Treated | Uncontrolled hypertension untreated

Datatype

boolean

Alias
UMLS CUI [1,1]
C1868885
UMLS CUI [1,2]
C1522326
UMLS CUI [2,1]
C1868885
UMLS CUI [2,2]
C0332155
known or suspected allergy to trial products or related products
Beschrijving

Hypersensitivity Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Related | Hypersensitivity Suspected Investigational New Drugs | Hypersensitivity Suspected Pharmaceutical Preparations Related

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0013227
UMLS CUI [2,3]
C0439849
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0750491
UMLS CUI [3,3]
C0013230
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0750491
UMLS CUI [4,3]
C0013227
UMLS CUI [4,4]
C0439849
use of any drug (except for oads), which in the investigator's opinion could interfere with the subject's glucose level or body weight
Beschrijving

Pharmaceutical Preparation Interferes with Glucose level | Pharmaceutical Preparation Interferes with Body Weight | Antidiabetics Oral

Datatype

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0428548
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0005910
UMLS CUI [3,1]
C0935929
UMLS CUI [3,2]
C1527415
active hepatitis b and/or active hepatitis c
Beschrijving

Hepatitis B | Hepatitis C

Datatype

boolean

Alias
UMLS CUI [1]
C0019163
UMLS CUI [2]
C0019196
positive hiv (human immunodeficiency virus) antibodies
Beschrijving

HIV antibody positive

Datatype

boolean

Alias
UMLS CUI [1]
C0920548
known or suspected abuse of alcohol or narcotics
Beschrijving

Alcohol abuse | Narcotic Abuse | Alcohol abuse Suspected | Narcotic Abuse Suspected

Datatype

boolean

Alias
UMLS CUI [1]
C0085762
UMLS CUI [2]
C0524661
UMLS CUI [3,1]
C0085762
UMLS CUI [3,2]
C0750491
UMLS CUI [4,1]
C0524661
UMLS CUI [4,2]
C0750491
habitual excessive consumption of methylxanthine-containing beverages and foods (coffee, tea, cola drinks, chocolate) as judged by the investigator
Beschrijving

Consumption Excessive Beverages methylxanthine | Consumption Excessive Food methylxanthine | Consumption Excessive Coffee | Consumption Excessive Tea | Consumption Excessive Cola drink | Consumption Excessive Hot chocolate drink

Datatype

boolean

Alias
UMLS CUI [1,1]
C0009830
UMLS CUI [1,2]
C0442802
UMLS CUI [1,3]
C0005329
UMLS CUI [1,4]
C0066447
UMLS CUI [2,1]
C0009830
UMLS CUI [2,2]
C0442802
UMLS CUI [2,3]
C0016452
UMLS CUI [2,4]
C0066447
UMLS CUI [3,1]
C0009830
UMLS CUI [3,2]
C0442802
UMLS CUI [3,3]
C0009237
UMLS CUI [4,1]
C0009830
UMLS CUI [4,2]
C0442802
UMLS CUI [4,3]
C0039400
UMLS CUI [5,1]
C0009830
UMLS CUI [5,2]
C0442802
UMLS CUI [5,3]
C0452444
UMLS CUI [6,1]
C0009830
UMLS CUI [6,2]
C0442802
UMLS CUI [6,3]
C0452243
Terug naar het begin van de pagina

Similar models

Eligibility Diabetes NCT01511692

1 Formulieren
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01511692
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes mellitus
boolean
C0011860 (UMLS CUI [1])
Diet therapy Non-Insulin-Dependent Diabetes Mellitus | Antidiabetics Oral Non-Insulin-Dependent Diabetes Mellitus
Item
diet-treated subjects and/or subjects with type 2 diabetes in oad (oral anti-diabetic drug) mono-therapy
boolean
C0012159 (UMLS CUI [1,1])
C0011860 (UMLS CUI [1,2])
C0935929 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0011860 (UMLS CUI [2,3])
Glycosylated hemoglobin A Percentage Diet therapy | Glycosylated hemoglobin A Percentage Antidiabetics Oral
Item
hba1c for diet-treated subjects: hba1c between 6.5-10.0% (both inclusive) and for oad treated subjects: hba1c between 6.5-9.5% (both inclusive)
boolean
C0019018 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0012159 (UMLS CUI [1,3])
C0019018 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C0935929 (UMLS CUI [2,3])
C1527415 (UMLS CUI [2,4])
Body mass index
Item
body mass index (bmi) between 27-40 kg/m^2 (both inclusive)
boolean
C1305855 (UMLS CUI [1])
Stable body weight | Body Weight Screening procedure
Item
subjects should have a stable body weight for at least 3 months prior to screening (as documented by a weight within 3 to 6 months, prior to screening that is within 15% of the screening weight)
boolean
C0517386 (UMLS CUI [1])
C0005910 (UMLS CUI [2,1])
C0220908 (UMLS CUI [2,2])
Euthyroid
Item
euthyroid subjects
boolean
C0117002 (UMLS CUI [1])
Eating normal
Item
subjects should be unrestrained eaters
boolean
C0566568 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Recurrent severe hypoglycemia
Item
recurrent severe hypoglycaemia
boolean
C0342316 (UMLS CUI [1])
Liver Dysfunction
Item
impaired liver function
boolean
C0086565 (UMLS CUI [1])
Renal Insufficiency
Item
impaired renal function
boolean
C1565489 (UMLS CUI [1])
cardiac problem
Item
cardiac problems
boolean
C0262402 (UMLS CUI [1])
Uncontrolled hypertension Treated | Uncontrolled hypertension untreated
Item
uncontrolled treated/untreated hypertension
boolean
C1868885 (UMLS CUI [1,1])
C1522326 (UMLS CUI [1,2])
C1868885 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
Hypersensitivity Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Related | Hypersensitivity Suspected Investigational New Drugs | Hypersensitivity Suspected Pharmaceutical Preparations Related
Item
known or suspected allergy to trial products or related products
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0439849 (UMLS CUI [2,3])
C0020517 (UMLS CUI [3,1])
C0750491 (UMLS CUI [3,2])
C0013230 (UMLS CUI [3,3])
C0020517 (UMLS CUI [4,1])
C0750491 (UMLS CUI [4,2])
C0013227 (UMLS CUI [4,3])
C0439849 (UMLS CUI [4,4])
Pharmaceutical Preparation Interferes with Glucose level | Pharmaceutical Preparation Interferes with Body Weight | Antidiabetics Oral
Item
use of any drug (except for oads), which in the investigator's opinion could interfere with the subject's glucose level or body weight
boolean
C0013227 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0428548 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0005910 (UMLS CUI [2,3])
C0935929 (UMLS CUI [3,1])
C1527415 (UMLS CUI [3,2])
Hepatitis B | Hepatitis C
Item
active hepatitis b and/or active hepatitis c
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
HIV antibody positive
Item
positive hiv (human immunodeficiency virus) antibodies
boolean
C0920548 (UMLS CUI [1])
Alcohol abuse | Narcotic Abuse | Alcohol abuse Suspected | Narcotic Abuse Suspected
Item
known or suspected abuse of alcohol or narcotics
boolean
C0085762 (UMLS CUI [1])
C0524661 (UMLS CUI [2])
C0085762 (UMLS CUI [3,1])
C0750491 (UMLS CUI [3,2])
C0524661 (UMLS CUI [4,1])
C0750491 (UMLS CUI [4,2])
Consumption Excessive Beverages methylxanthine | Consumption Excessive Food methylxanthine | Consumption Excessive Coffee | Consumption Excessive Tea | Consumption Excessive Cola drink | Consumption Excessive Hot chocolate drink
Item
habitual excessive consumption of methylxanthine-containing beverages and foods (coffee, tea, cola drinks, chocolate) as judged by the investigator
boolean
C0009830 (UMLS CUI [1,1])
C0442802 (UMLS CUI [1,2])
C0005329 (UMLS CUI [1,3])
C0066447 (UMLS CUI [1,4])
C0009830 (UMLS CUI [2,1])
C0442802 (UMLS CUI [2,2])
C0016452 (UMLS CUI [2,3])
C0066447 (UMLS CUI [2,4])
C0009830 (UMLS CUI [3,1])
C0442802 (UMLS CUI [3,2])
C0009237 (UMLS CUI [3,3])
C0009830 (UMLS CUI [4,1])
C0442802 (UMLS CUI [4,2])
C0039400 (UMLS CUI [4,3])
C0009830 (UMLS CUI [5,1])
C0442802 (UMLS CUI [5,2])
C0452444 (UMLS CUI [5,3])
C0009830 (UMLS CUI [6,1])
C0442802 (UMLS CUI [6,2])
C0452243 (UMLS CUI [6,3])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial